Renal lipotoxicity-associated inflammation and insulin resistance affects actin cytoskeleton organization in podocytes

PLoS ONE

Volumn 10, Issue 11, 2015, Pages

  Martínez García, Cristina ^a   Izquierdo Lahuerta, Adriana ^a   Vivas, Yurena ^a   Velasco, Ismael ^a   Yeo, Tet Kin ^b   Chen, Sheldon ^b,c   Medina Gomez, Gema ^a  

^a UNIVERSIDAD REY JUAN CARLOS   (Spain)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ACETYL COENZYME A OXIDASE; CYCLOOXYGENASE 2; CYTOCHALASIN D; FAS ANTIGEN; FAT DROPLET; FIBROBLAST GROWTH FACTOR 21; GLUCOSE; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 4; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; INTERLEUKIN 6; MESSENGER RNA; NEPHRIN; OXIDOREDUCTASE; P CADHERIN; PALMITIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PYRUVATE CARBOXYLASE; SERINE PALMITOYL TRANSFERASE 1; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR RELA; TRANSFERASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG; VIMENTIN;

ACTIN FILAMENT; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; CYTOARCHITECTURE; ENDOPLASMIC RETICULUM STRESS; ENZYME PHOSPHORYLATION; FATTY ACID SYNTHESIS; GENE EXPRESSION; GLUCOSE METABOLISM; INFLAMMATION; INSULIN RESISTANCE; KIDNEY DISEASE; LIPID STORAGE; LIPOTOXICITY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PODOCYTE; ANIMAL; CELL LINE; CHEMISTRY; DRUG EFFECTS; KIDNEY; LIPID METABOLISM; METABOLISM;

ACTIN CYTOSKELETON; ANIMALS; APOPTOSIS; CELL LINE; CYTOCHALASIN D; ENDOPLASMIC RETICULUM STRESS; INFLAMMATION; INSULIN RESISTANCE; KIDNEY; LIPID METABOLISM; MICE; OXIDATIVE STRESS; PALMITIC ACID; PODOCYTES;

EID: 84952332569     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0142291     Document Type: Article

References (69)

1. Wild. Estimates for the year 2000 and projections for 2030. World Health. 2004; 27: 1047-1053.
2. Haffner SM. Risk Constellations in Patients with the Metabolic Syndrome: Epidemiology, Diagnosis, and Treatment Patterns. Am J Med. Elsevier; 2015; 119: S3-S9. doi: 10.1016/j.amjmed.2006.01.008
3. Moorhead JF, El-Nahas M, Chan MK, Varghese Z. Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet. Elsevier; 2015; 320: 1309-1311. doi: 10.1016/S0140-6736 (82)91513-6
4. Ruan XZ, Moorhead JF, Fernando R, Wheeler DC, Powis SH, Varghese Z. Regulation of lipoprotein trafficking in the kidney: role of inflammatory mediators and transcription factors. Biochem Soc Trans. 2004; 32: 88-91. doi: 10.1042/BST0320088 PMID: 14748720
5. Ke Wf. Lipids and the kidney. Kidney Int. 1994; 46: 910-20. PMID: 7996813
6. Ziyadeh FN. Mediators of diabetic renal disease: the case for tgf-Beta as the major mediator. J Am Soc Nephrol. 2004; 15 Suppl 1: S55-S57. doi: 10.1097/01.ASN.0000093460.24823.5B PMID: 14684674
7. Merscher S, Fornoni A. Podocyte pathology and nephropathy-sphingolipids in glomerular diseases. Frontiers in Endocrinology. 2014. doi: 10.3389/fendo.2014.00127 PMID: 25126087
8. Braissant O, Wahli W. Differential Expression of Peroxisome Proliferator-Activated Receptor-α, -β, and -γ during Rat Embryonic Development. Endocrinology. The Endocrine Society; 1998; 139: 2748-2754. doi: 10.1210/endo.139.6.6049 PMID: 9607781
9. Lee HS, Kim BC, Hong HK, Kim YS. LDL stimulates collagen mRNA synthesis in mesangial cells through induction of PKC and TGF-beta expression. Am J Physiol. 1999; 277: F369-F376. PMID: 10484520
10. Joles J a, Kunter U, Janssen U, Kriz W, Rabelink TJ, Koomans H a, et al. Early mechanisms of renal injury in hypercholesterolemic or hypertriglyceridemic rats. J Am Soc Nephrol. 2000; 11: 669-683. PMID: 10752526
11. Welsh GI, Saleem M a. The podocyte cytoskeleton-key to a functioning glomerulus in health and disease. Nat Rev Nephrol. Nature Publishing Group; 2011; 8: 14-21. doi: 10.1038/nrneph.2011.151
12. Brown EJ, Schlöndorff JS, Becker DJ, Uscinski AL, Higgs HN, Henderson JM, et al. NIH Public Access. 2010; 42: 72-76. doi: 10.1038/ng.505.Mutations
13. Machuca E, Benoit G, Antignac C. Genetics of nephrotic syndrome: Connecting molecular genetics to podocyte physiology. Hum Mol Genet. 2009; 18: 185-194. doi: 10.1093/hmg/ddp328
14. Leeuwis JW, Nguyen TQ, Dendooven A, Kok RJ, Goldschmeding R. Targeting podocyte-associated diseases. Adv Drug Deliv Rev. Elsevier B.V.; 2010; 62: 1325-1336. doi: 10.1016/j.addr.2010.08.012 PMID: 20828590
15. Mundel P, Reiser J, Zúñiga Mejía Borja a, Pavenstädt H, Davidson GR, Kriz W, et al. Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. Exp Cell Res. 1997; 236: 248-258. doi: 10.1006/excr.1997. 3739 PMID: 9344605
16. Lavin PJ, Gbadegesin R, Damodaran T V, Winn MP. Therapeutic targets in focal and segmental glomerulosclerosis. Curr Opin Nephrol Hypertens. 2008; 17: 386-392. doi: 10.1097/MNH. 0b013e32830464f4 PMID: 18660675
17. Chuang PY, He JC. Signaling in Regulation of Podocyte Phenotypes. Nephron Physiol. 2009; 111: p9-15. doi: 10.1159/000191075 PMID: 19142027
18. Kwoh C, Shannon MB, Miner JH, Shaw A. PATHOGENESIS OF NONIMMUNE GLOMERULOPATHIES. Annu Rev Pathol Mech Dis. Annual Reviews; 2006; 1: 349-374. doi: 10.1146/annurev.pathol. 1.110304.100119
19. Ha T-S, Hong E-J, Han G-D. Diabetic conditions downregulate the expression of CD2AP in podocytes via PI3-K/Akt signalling. Diabetes Metab Res Rev. 2015; 31: 50-60. doi: 10.1002/dmrr.2562 PMID: 24846128
20. Mundel P, Shankland SJ. Podocyte biology and response to injury. J Am Soc Nephrol. 2002; 13: 3005-3015. doi: 10.1097/01.ASN.0000039661.06947.FD PMID: 12444221
21. Pavenstädt H, Kriz W, Kretzler M. Cell biology of the glomerular podocyte. Physiol Rev. 2003; 83: 253-307. doi: 10.1152/physrev.00020.2002 PMID: 12506131
22. Li X, Zhang X, Li X, Ding F, Ding J. The Role of Survivin in Podocyte Injury Induced by Puromycin Aminonucleoside. Int J Mol Sci. 2014; 15: 6657-6673. doi: 10.3390/ijms15046657 PMID: 24747598
23. Bijian K, Takano T, Papillon J, Le Berre L, Michaud J-L, Kennedy CRJ, et al. Actin cytoskeleton regulates extracellular matrix-dependent survival signals in glomerular epithelial cells. Am J Physiol Renal Physiol. 2005
24. Ichimura K, Kurihara H, Sakai T. Actin filament organization of foot processes in vertebrate glomerular podocytes. Cell Tissue Res. 2007; 329: 541-557. doi: 10.1007/s00441-007-0440-4 PMID: 17605050
25. Ichimura K, Kurihara H, Sakai T. Actin filament organization of foot processes in rat podocytes. J Histochem Cytochem. United States; 2003; 51: 1589-1600. PMID: 14623927
26. Coward RJM, Welsh GI, Yang J, Tasman C, Lennon R, Koziell A, et al. The human glomerular podocyte is a novel target for insulin action. Diabetes. 2005
27. Martinez-Garcia C, Izquierdo A, Velagapudi V, Vivas Y, Velasco I, Campbell M, et al. Accelerated renal disease is associated with the development of metabolic syndrome in a glucolipotoxic mouse model. Disease Models & Mechanisms. 2012.
28. Jat PS, Noble MD, Ataliotis P, Tanaka Y, Yannoutsos N, Larsen L, et al. Direct derivation of conditionally immortal cell lines from an H-2Kb-tsA58 transgenic mouse. Proc Natl Acad Sci U S A. 1991; 88: 5096-5100. doi: 10.1073/pnas.88.12.5096 PMID: 1711218
29. Schmitz-Peiffer C, Craig DL, Biden TJ. Ceramide generation is sufficient to account for the inhibition of the insulin-stimulated PKB pathway in C2C12 skeletal muscle cells pretreated with palmitate. J Biol Chem. 1999; 274: 24202-24210. doi: 10.1074/jbc.274.34.24202 PMID: 10446195
30. Lennon R, Pons D, Sabin MA, Wei C, Shield JP, Coward RJ, et al. Saturated fatty acids induce insulin resistance in human podocytes: Implications for diabetic nephropathy. Nephrol Dial Transplant. 2009
31. Daniela Macconi and GR. Permselective dysfunction of podocyte-podocyte contact upon angiotensin II unravels the molecular target for renoprotective intervention. Am J Pathol. 2006; 168: 1073-85. PMID: 16565484
32. Vivas Y, Martinez-Garcia C, Izquierdo A, Garcia-Garcia F, Callejas S, Velasco I, et al. Early Peroxisome proliferator-activated receptor gamma regulated genes involved in expansion of pancreatic beta cell mass. BMC Med Genomics. BioMed Central Ltd; 2011; 4: 86. doi: 10.1186/1755-8794-4-86 PMID: 22208362
33. MM B. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976; 7: 248-54.
34. Lee EY, Chung CH, Khoury CC, Yeo TK, Pyagay PE, Wang A, et al. The monocyte chemoattractant protein-1/CCR2 loop, inducible by TGF-beta, increases podocyte motility and albumin permeability. Am J Physiol Renal Physiol. 2009; 297: F85-F94. doi: 10.1152/ajprenal.90642.2008 PMID: 19420107
35. Xaus J, Comalada M, Cardó M, Valledor AF, Celada A. Decorin inhibits macrophage colony-stimulating factor proliferation of macrophages and enhances cell survival through induction of p27Kip1 and p21Waf1. Blood. 2001; 98: 2124-2133. doi: 10.1182/blood.V98.7.2124 PMID: 11567999
36. Jiménez-Altayó F, Briones a. M, Giraldo J, Planas a. M, Salaices M, Vila E. Increased Superoxide Anion Production by Interleukin-1 beta Impairs Nitric Oxide-Mediated Relaxation in Resistance Arteries. J Pharmacol. 2006; 316: 42-52. doi: 10.1124/jpet.105.088435.to
37. Ozcan U, Yilmaz E, Ozcan L, Furuhashi M, Vaillancourt E, Smith RO, et al. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science. United States; 2006; 313: 1137-1140. doi: 10.1126/science.1128294 PMID: 16931765
38. Madhusudhan T, Wang H, Dong W, Ghosh S, Bock F, Thangapandi VR, et al. Defective podocyte insulin signalling through p85-XBP1 promotes ATF6-dependent maladaptive ER-stress response in diabetic nephropathy. Nat Commun. Nature Publishing Group; 2015; 6: 6496. doi: 10.1038/ncomms7496 PMID: 25754093
39. Crean JKG, Finlay D, Murphy M, Moss C, Godson C, Martin F, et al. The role of p42/44 MAPK and protein kinase B in connective tissue growth factor induced extracellular matrix protein production, cell migration, and actin cytoskeletal rearrangement in human mesangial cells. J Biol Chem. 2002; 277: 44187-44194. doi: 10.1074/jbc.M203715200 PMID: 12218048
40. Welsh GI, Hale LJ, Eremina V, Jeansson M, Maezawa Y, Lennon R, et al. Insulin signaling to the glomerular podocyte is critical for normal kidney function. Cell Metab. United States; 2010; 12: 329-340. doi: 10.1016/j.cmet.2010.08.015
41. Goddettes DW, Frieden C. Actin Polymerization. 1986; 15974-15980.
42. Katz H, Fornoni A, Merscher S, Kopp JB. Lipid biology of the podocyte-new perspectives offer new opportunities. Nat Rev Nephrol. 2014; 10: 379-388. doi: 10.1038/nrneph.2014.87 PMID: 24861084
43. Kume S, Uzu T, Araki S, Sugimoto T, Isshiki K, Chin-Kanasaki M, et al. Role of altered renal lipid metabolism in the development of renal injury induced by a high-fat diet. J Am Soc Nephrol. 2007; 18: 2715-2723. doi: 10.1681/ASN.2007010089 PMID: 17855643
44. Hivert M-F, Sullivan LM, Fox CS, Nathan DM, D'Agostino RB, Wilson PWF, et al. Associations of Adiponectin, Resistin, and Tumor Necrosis Factor-α with Insulin Resistance. J Clin Endocrinol Metab. The Endocrine Society; 2008; 93: 3165-3172. doi: 10.1210/jc.2008-0425 PMID: 18492747
45. Nam BY, Paeng J, Kim SH, Lee SH, Kim DH, Kang HY, et al. The MCP-1/CCR2 axis in podocytes is involved in apoptosis induced by diabetic conditions. Apoptosis. 2012; 17: 1-13. doi: 10.1007/s10495- 011-0661-6 PMID: 22006533
46. Schenk S, Saberi M, Olefsky JM. Insulin sensitivity: Modulation by nutrients and inflammation. J Clin Invest. 2008; 118: 2992-3002. doi: 10.1172/JCI34260 PMID: 18769626
47. Shoelson SE, Lee J, Goldfine AB. Review series Inflammation and insulin resistance. J Clin Invest. 2006; 116: 1793-1801. doi: 10.1172/JCI29069.and PMID: 16823477
48. Thomas ME, Morrison AR, Schreiner GF. Metabolic effects of fatty acid-bearing albumin on a proximal tubule cell line. Am J Physiol-Ren Physiol. 1995; 268: F1177-F1184. Available: http://ajprenal. physiology.org/content/268/6/F1177.abstract
49. Thomas ME, Harris KP, Ramaswamy C, Hattersley JM, Wheeler DC, Varghese Z, Williams JD, Walls J MJ. Simvastatin therapy for hypercholesterolemic patients with nephrotic syndrome or significant proteinuria. Kidney Int. 1993; 44: 1124-9. PMID: 8264145
50. Thomas ME, Harris KPG, Walls J, Furness PN, Brunskill NJ. Fatty acids exacerbate tubulointerstitial injury in protein-overload proteinuria. Am J Physiol Renal Physiol. 2002; 283: F640-F647. doi: 10. 1152/ajprenal.00001.2002 PMID: 12217854
51. Gao Z, Zhang X, Zuberi A, Hwang D, Quon MJ, Lefevre M, et al. Inhibition of insulin sensitivity by free fatty acids requires activation of multiple serine kinases in 3T3-L1 adipocytes. Mol Endocrinol. 2004; 18: 2024-2034. doi: 10.1210/me.2003-0383 PMID: 15143153
52. Gao D, Nong S, Huang X, Lu Y, Zhao H, Lin Y, et al. The effects of palmitate on hepatic insulin resistance are mediated by NADPH oxidase 3-derived reactive oxygen species through JNK and p38 MAPK pathways. J Biol Chem. 2010; 285: 29965-29973. doi: 10.1074/jbc.M110.128694 PMID: 20647313
53. Morino K, Neschen S, Bilz S, Sono S, Tsirigotis D, Reznick RM, et al. Muscle-Specific IRS-1 Ser 3 Ala Transgenic Mice Are Skeletal Muscle. 2014; 57. doi: 10.2337/db06-0454.K.M.
54. Senn JJ. Toll-like receptor-2 is essential for the development of palmitate-induced insulin resistance in myotubes. J Biol Chem. 2006; 281: 26865-26875. doi: 10.1074/jbc.M513304200 PMID: 16798732
55. Rotter V, Nagaev I, Smith U. Interleukin-6 (IL-6) Induces Insulin Resistance in 3T3-L1 Adipocytes and Is, Like IL-8 and Tumor Necrosis Factor-α, Overexpressed in Human Fat Cells from Insulin-resistant Subjects. J Biol Chem. 2003; 278: 45777-45784. doi: 10.1074/jbc.M301977200 PMID: 12952969
56. Valverde AM, González-Rodríguez A. IRS2 and PTP1B: Two opposite modulators of hepatic insulin signalling. Arch Physiol Biochem. 2011; 117: 105-115. doi: 10.3109/13813455.2011.557386 PMID: 21401320
57. González-rodríguez Á, Más-gutierrez J a, Mirasierra M, Lee YJ, Ko HJ, Kim JK, et al. NIH Public Access. 2013; 11: 284-296. doi: 10.1111/j.1474-9726.2011.00786.x.ESSENTIAL
58. Hale LJ, Mathieson W, Welsh GI, Coward RJ, Hurcombe J, Lay A, et al. glomerular podocyte Insulin directly stimulates VEGF-A production in the Insulin directly stimulates VEGF-A production in the glomerular podocyte. Am J Physiol Ren Physiol. 2013; 305: 182-188. doi: 10.1152/ajprenal.00548.2012
59. Chavez-Tapia NC, Rosso N, Tiribelli C. Effect of intracellular lipid accumulation in a new model of nonalcoholic fatty liver disease. BMC Gastroenterol. BioMed Central Ltd; 2012; 12: 20. doi: 10.1186/1471- 230X-12-20 PMID: 22380754
60. Kamata H, Oka S, Shibukawa Y, Kakuta J HH. Redox regulation of nerve growth factor-induced neuronal differentiation of PC12 cells through modulation of the nerve growth factor receptor, TrkA. Arch Biochem Biophys. 2005; 434: 16-25. PMID: 15629104
61. Ijaz A, Tejada T, Catanuto P, Xia X, Elliot SJ, Lenz O, et al. Inhibition of C-jun N-terminal kinase improves insulin sensitivity but worsens albuminuria in experimental diabetes. Kidney Int. 2009; 75: 381-388. doi: 10.1038/ki.2008.559 PMID: 18971923
62. Ariyama H, Kono N, Matsuda S, Inoue T, Arai H. Decrease in membrane phospholipid unsaturation induces unfolded protein response. J Biol Chem. 2010; 285: 22027-22035. doi: 10.1074/jbc.M110. 126870 PMID: 20489212
63. Thörn K, Bergsten P. Fatty acid-induced oxidation and triglyceride formation is higher in insulin-producing MIN6 cells exposed to oleate compared to palmitate. J Cell Biochem. Wiley Subscription Services, Inc., A Wiley Company; 2010; 111: 497-507. doi: 10.1002/jcb.22734 PMID: 20524206
64. Hagen RM, Rodriguez-Cuenca S, Vidal-Puig A. An allostatic control of membrane lipid composition by SREBP1. FEBS Lett. Federation of European Biochemical Societies; 2010; 584: 2689-2698. doi: 10. 1016/j.febslet.2010.04.004
65. Coward RJM, Foster RR, Patton D, Ni L, Lennon R, Bates DO, et al. Nephrotic plasma alters slit diaphragm- dependent signaling and translocates nephrin, Podocin, and CD2 associated protein in cultured human podocytes. J Am Soc Nephrol. 2005; 16: 629-637. doi: 10.1681/ASN.2004030172 PMID: 15659563
66. Müller-Krebs S, Weber L, Tsobaneli J, Kihm LP, Reiser J, Zeier M, et al. Cellular effects of Everolimus and Sirolimus on podocytes. PLoS One. 2013; 8: 1-13. doi: 10.1371/journal.pone.0080340
67. Steffes MW. Affecting the decline of renal function in diabetes mellitus. Kidney Int. 2001; 60: 378-379. doi: 10.1046/j.1523-1755.2001.00812.x PMID: 11422776
68. Németh ZH, Deitch EA, Davidson MT, Szabó C, Vizi ES, Haskó G. Disruption of the actin cytoskeleton results in nuclear factor-κB activation and inflammatory mediator production in cultured human intestinal epithelial cells. J Cell Physiol. Wiley Subscription Services, Inc., A Wiley Company; 2004; 200: 71-81. doi: 10.1002/jcp.10477 PMID: 15137059
69. Carobbio S, Rodriguez-Cuenca S, Vidal-Puig A. Origins of metabolic complications in obesity. Curr Opin Clin Nutr Metab Care. 2011; 14: 520-526. doi: 10.1097/MCO.0b013e32834ad966 PMID: 21849895